Michael Wang, Author at NFCR

Michael Wang

NFCR’s Genomics Newsroom: New genes linked to increased risk of ovarian and brain cancer

What is “genomics”? Cancer develops when genetic material (DNA) becomes damaged or changed. We know some cancer causing genetic changes are acquired (i.e. smoking), while others are inherited. Studying cancer genomics explores the differences between cancer cells and normal cells. Advances in understanding how cancer behaves at a genomic and…...

Read more

Nano-Particles Open New Window for Biological Imaging

“Quantum dots” that emit infrared light enable highly detailed images of internal body structures Researchers have found a way to make tiny particles, known as quantum dots, that can be injected into the body and emit short-wave infrared light, enabling a new way to capture detailed images of internal body…...

Read more

NFCR’s Genomics Newsroom: Using Molecular Imaging to Guide Cancer Therapy

Molecular imaging combines conventional anatomic imaging with genomic testing and enables doctors to literally see cancer at its molecular or genetic level....

Read more

NFCR’s Genomics Newsroom: Bladder Cancer Could Be Treated the Same Way as Breast Cancer

Researchers from UNC, Chapel Hill found a subtype of bladder cancer has the same molecular signatures as a subset of breast cancer....

Read more

NFCR’s Genomics Newsroom: New Method to Detect Biomarkers

A method called MishCTC is being developed that will detect a molecular biomarker that is inside tumor cells but can’t be detected in normal blood cells....

Read more

NFCR’s Genomics Newsroom: Discovery of New Lung Cancer Mutation

The U.S. FDA approved the first and only drug to treat people with advanced non-small cell lung cancer (NSCLC) whose tumors express the ROS1+ mutation....

Read more

Renal Cell Carcinoma Treatment

A new molecular discovery will allow doctors to select more effective treatment approaches based on the 9 subtypes of Renal Cell Carcinoma....

Read more